Adjuvant thyroid remnant ablation in patients with differentiated thyroid carcinoma confined to the thyroid: a comparison of ablation success with different activities of radioiodine (I-131)

Three-dimensional radiobiological dosimetry (3D-RD) with 124I PET for 131I therapy of thyroid cancer

(2011) George Sgouros et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

The Benefits and Risks of I-131 Therapy in Patients with Well-Differentiated Thyroid Cancer

(2009) Douglas Van Nostrand   THYROID

Revised American Thyroid Association Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer

(2009) David S. Cooper et al.   THYROID

Serum thyroglobulin determination in thyroid cancer patients

(2008) Zélia Francis et al.   BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM

Radio-iodine therapy in differentiated thyroid cancer: indications and procedures

(2008) Christoph Reiners et al.   BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM

Why radioiodine remnant ablation is right for most patients with differentiated thyroid carcinoma

(2008) Frederik A. Verburg et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Low vs. High Radioiodine Activity to Ablate the Thyroid after Thyroidectomy for Cancer: A Randomized Study

(2008) Hanna O. Mäenpää et al.   PLoS One